ATE27822T1 - Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus. - Google Patents
Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus.Info
- Publication number
- ATE27822T1 ATE27822T1 AT85400168T AT85400168T ATE27822T1 AT E27822 T1 ATE27822 T1 AT E27822T1 AT 85400168 T AT85400168 T AT 85400168T AT 85400168 T AT85400168 T AT 85400168T AT E27822 T1 ATE27822 T1 AT E27822T1
- Authority
- AT
- Austria
- Prior art keywords
- hexapeptide
- processes
- preparation
- pharmaceutical compositions
- pro
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- ZQOILFFBJUNGRA-NMVUUJPQSA-N (4s)-4-[[(2s)-2-amino-3-methylbutanoyl]amino]-5-[(2s)-2-[[(2s,3s)-1-[(2s)-2-[[(1s)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid Chemical compound N([C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)C(C)C ZQOILFFBJUNGRA-NMVUUJPQSA-N 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 108010030651 valyl-glutamyl-prolyl-isoleucyl-prolyl-tyrosine Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8401816A FR2559157B1 (fr) | 1984-02-07 | 1984-02-07 | Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent |
| EP85400168A EP0155199B1 (de) | 1984-02-07 | 1985-02-01 | Hexapeptid, Verfahren zur Herstellung und pharmazeutische Zusammensetzungen hieraus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE27822T1 true ATE27822T1 (de) | 1987-07-15 |
Family
ID=9300812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85400168T ATE27822T1 (de) | 1984-02-07 | 1985-02-01 | Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4637997A (de) |
| EP (1) | EP0155199B1 (de) |
| JP (1) | JPS60188399A (de) |
| AT (1) | ATE27822T1 (de) |
| CA (1) | CA1250810A (de) |
| DE (1) | DE3560262D1 (de) |
| FR (1) | FR2559157B1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0680014B2 (ja) * | 1985-12-10 | 1994-10-12 | 雪印乳業株式会社 | 低分子ペプチドを有効成分とする免疫賦活剤及びその調製法 |
| DE3736589A1 (de) * | 1987-10-29 | 1989-05-11 | Behringwerke Ag | Glutaminhaltige peptide, verfahren zu deren herstellung und verwendung |
| DE69423243T2 (de) * | 1994-05-12 | 2000-11-02 | Orsolya Csuka | Stoffe zur aufhebung von arzneimittelresistenzen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3558770A (en) * | 1967-09-01 | 1971-01-26 | Kraftco Corp | Wound treating composition employing an enzyme modified casein |
| FR2491334A1 (fr) * | 1980-10-03 | 1982-04-09 | Inst Nat Sante Rech Med | Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant |
| FR2513881A2 (fr) * | 1980-10-03 | 1983-04-08 | Inst Nat Sante Rech Med | Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant |
-
1984
- 1984-02-07 FR FR8401816A patent/FR2559157B1/fr not_active Expired
-
1985
- 1985-02-01 AT AT85400168T patent/ATE27822T1/de not_active IP Right Cessation
- 1985-02-01 EP EP85400168A patent/EP0155199B1/de not_active Expired
- 1985-02-01 DE DE8585400168T patent/DE3560262D1/de not_active Expired
- 1985-02-04 US US06/697,903 patent/US4637997A/en not_active Expired - Fee Related
- 1985-02-05 JP JP60019373A patent/JPS60188399A/ja active Pending
- 1985-02-06 CA CA000473682A patent/CA1250810A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1250810A (fr) | 1989-03-07 |
| EP0155199B1 (de) | 1987-06-16 |
| DE3560262D1 (en) | 1987-07-23 |
| US4637997A (en) | 1987-01-20 |
| FR2559157A1 (fr) | 1985-08-09 |
| JPS60188399A (ja) | 1985-09-25 |
| EP0155199A1 (de) | 1985-09-18 |
| FR2559157B1 (fr) | 1986-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69111175D1 (de) | Verfahren zur Herstellung modifizierter proteinischer Produkte und Zusammensetzungen daraus. | |
| EP0909814A3 (de) | Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit | |
| EP1440980A3 (de) | Peptidanaloge des menschlichen, basischen Myelinproteins | |
| WO2000053758A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
| IL112585A (en) | N-terminally chemically modified G-CSF and analogs process for their preparation and pharmaceutical compositions containing them | |
| ATE108662T1 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
| HUT44433A (en) | Process for preparing compositions comprising unsaturated fatty acids necessary for the synthesis of prostaglandines and hydroxy-fatty acids in biological systems | |
| DE69129899D1 (de) | Verfahren zur Herstellung von D-Alpha-Aminosäuren | |
| WO1996028470A3 (en) | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis | |
| ATE213499T1 (de) | Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose | |
| DE69420827D1 (de) | Verfahren zur Herstellung von wässrigen Emulsionen zur Umhüllung von festen pharmazeutischen Zusammensetzungen | |
| DE3462039D1 (en) | Peptide derivatives, their preparation and use as elastase inhibitors | |
| AU4011300A (en) | Compositions and methods for the treatment of immune related diseases | |
| WO1999014241A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| DE3886213D1 (de) | Verfahren zur Herstellung von Antioxidant-Zubereitungen. | |
| DK482185D0 (da) | Peptider, deres fremstilling og anvendelse som laegemidler | |
| DE68911571D1 (de) | Verfahren zur Herstellung von Silikonschaum-Zusammensetzungen. | |
| ATE107859T1 (de) | Verwendung von antiprogestomimetika zur stimulierung des eisprungs. | |
| EP0249248A3 (de) | Purinderivate | |
| DE59004490D1 (de) | Verfahren zur Herstellung von alpha-Fluoracrylsäurederivaten. | |
| PT87535A (pt) | Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same | |
| ATE27822T1 (de) | Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus. | |
| HUT52117A (en) | Process for producing amblyommin and process for producing pharmaceutical compositions comprising such compound as active ingredient | |
| DE69018079D1 (de) | Verfahren zur Herstellung wässriger beladener Latexzusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |